New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
10:04 EDTSNN, WMGI, SYK, TRNX, JNJ, IART, ZMHVolume trends from CCJR meeting positive for Zimmer, says Piper Jaffray
Piper Jaffray said it has more confidence in improving volume trends in the orthopedic market following its attendance at the Current Concepts in Joint Replacement meeting, which it views as particularly positive for Zimmer (ZMH). The firm also said the trends and expectations pointed to at the meeting were positive, but to a lesser extent, for Tornier (TRNX), Wright Medical (WMGI), Integra LifeSciences (IART), Stryker (SYK), Smith & Nephew (SNN) and Johnson & Johnson (JNJ).
News For ZMH;TRNX;WMGI;IART;SYK;SNN;JNJ From The Last 14 Days
Check below for free stories on ZMH;TRNX;WMGI;IART;SYK;SNN;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
05:42 EDTJNJIllumina announces strategic partnership with AstraZeneca, Sanofi, Janssen
Illumina (ILMN) announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing, or NGS,-based oncology test system. The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine. Initial strategic partners include AstraZeneca (AZN), Janssen Biotech, a Johnson & Johnson (JNJ) company, and Sanofi (SNY). Illumina is working with the strategic partners to develop assays that detect and measure multiple variants simultaneously to support partners’ clinical trials, with the objectives of securing regulatory agency approvals and test commercialization. In parallel, Illumina is working with key thought leaders to set standards for NGS-based assays in routine clinical oncology practice, as well as to define regulatory frameworks to enable this new testing paradigm. Together, Illumina and its strategic partners aim to transition from single-analyte companion diagnostics to panel-based assays that select for “companion therapeutics.”
August 18, 2014
16:14 EDTTRNXBridger reports 5.5% passive stake in Tornier
Subscribe for More Information
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
10:47 EDTZMHZimmer advances following analyst upgrade
Subscribe for More Information
10:01 EDTZMHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Hold at Deutsche Bank... CNOOC (CEO) upgraded to Neutral from Underperform at Credit Suisse... Dollar General (DG) upgraded to Buy from Neutral at Sterne Agee... Equity Residential (EQR) upgraded to Hold from Underperform at Jefferies... HMS Holdings (HMSY) upgraded to Overweight from Equal Weight at First Analysis... HP (HPQ) upgraded to Buy from Neutral at Monness Crespi... Halcon Resources (HK) upgraded to Buy from Hold at MLV & Co.... KapStone (KS) upgraded to Buy from Hold at Deutsche Bank... Sportsman's Warehouse (SPWH) upgraded at RW Baird... Westlake Chemical (WLK) upgraded to Neutral from Reduce at SunTrust... WisdomTree (WETF) upgraded to Neutral from Sell at Citigroup... Zimmer (ZMH) upgraded to Outperform from Market Perform at William Blair.
07:04 EDTZMHZimmer upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Zimmer Holdings to Outperform citing the recent pullback in shares and its belief the proposed Biomet acquisition will close.
August 15, 2014
10:01 EDTSNNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Apollo Global (APO) downgraded to Market Perform from Outperform at Wells Fargo... Calavo Growers (CVGW) downgraded to Neutral from Outperform at Wedbush... DaVita (DVA) downgraded to Hold from Buy at Deutsche Bank... Dangdang (DANG) downgraded to Neutral from Outperform at Credit Suisse... Ducommun (DCO) downgraded to Neutral from Buy at DA Davidson... Energy XXI (EXXI) downgraded to Sector Perform from Outperform at Howard Weil... Fifth Street Finance (FSC) downgraded to Neutral from Buy at Gilford Securities... Genetic Technologies (GENE) downgraded to Neutral from Buy at Ladenburg... Harmony Gold (HMY) downgraded to Underweight from Neutral at HSBC... Ignite Restaurant (IRG) downgraded to Neutral from Overweight at Piper Jaffray... JDSU (JDSU) downgraded to Hold from Buy at Argus... K12 (LRN) downgraded to Market Perform from Outperform at Wells Fargo... KKR (KKR) downgraded to Market Perform from Outperform at Wells Fargo... Lexington Realty (LXP) downgraded to Neutral from Buy at Ladenburg... Lithia Motors (LAD) downgraded to Underweight from Equal Weight at Morgan Stanley... New York & Co. (NWY) downgraded to Neutral from Buy at Janney Capital... OCI Partners (OCIP) downgraded to Underweight from Equal Weight at Barclays... OmniVision (OVTI) downgraded to Neutral from Outperform at RW Baird... Smith & Nephew (SNN) downgraded to Equal Weight from Overweight at Morgan Stanley... Subsea 7 (SUBCY) downgraded to Neutral from Buy at Goldman... Tencent (TCEHY) downgraded to Neutral from Overweight at JPMorgan... ViaSat (VSAT) downgraded to Equal Weight from Overweight at Stephens... bebe stores (BEBE) downgraded to Neutral from Buy at Janney Capital.
09:10 EDTSNNSmith & Nephew downgraded to Equal Weight from Overweight at Morgan Stanley
August 12, 2014
15:26 EDTIARTIntegra LifeSciences says two former sales representatives enter guilty pleas
Subscribe for More Information
10:00 EDTSYKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:56 EDTIARTIntegra LifeSciences management to meet with Oppenheimer
Subscribe for More Information
09:35 EDTJNJActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
06:22 EDTSYKStryker upgraded to Buy from Hold at Needham
Subscribe for More Information
August 8, 2014
10:00 EDTTRNXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Activision Blizzard (ATVI) upgraded to Buy from Neutral at Longbow... Allergan (AGN) upgraded to Outperform from Market Perform at Leerink... Andersons (ANDE) upgraded to Buy from Hold at Feltl... Arista Networks (ANET) upgraded to Buy from Neutral at Citigroup... Barrick Gold (ABX) upgraded to Conviction Buy from Buy at Goldman... Brinker (EAT) upgraded to Outperform from Market Perform at Raymond James... CF Industries (CF) upgraded to Buy from Hold at Feltl... CST Brands (CST) upgraded to Neutral from Underperform at Credit Suisse... Cimarex Energy (XEC) upgraded to Accumulate from Hold at KLR Group... Coca-Cola HBC (OCCH) upgraded to Buy from Hold at Deutsche Bank... Delek US (DK) upgraded to Outperform at Cowen... Fifth Street Finance (FSC) upgraded to Buy from Neutral at Guggenheim... Glimcher Realty Trust (GRT) upgraded to Buy from Neutral at BofA/Merrill... Goodrich Petroleum (GDP) upgraded to Strong Buy from Outperform at Raymond James... Monster Beverage (MNST) upgraded to Neutral from Underperform at Longbow... NIC Inc. (EGOV) upgraded to Outperform from Market Perform at Barrington... NVIDIA (NVDA) upgraded at Needham... POZEN (POZN) upgraded to Buy from Hold at Ascendiant... Power Solutions (PSIX) upgraded to Accumulate from Neutral at Global Hunter... Primoris (PRIM) upgraded to Buy from Hold at BB&T... Sierra Bancorp (BSRR) upgraded to Outperform from Market Perform at Raymond James... Sonus Networks (SONS) upgraded to Outperform from Market Perform at Barrington... Stone Energy (SGY) upgraded to Buy from Accumulate at KLR Group... Tornier (TRNX) upgraded at BMO Capital... Tyson Foods (TSN) upgraded to Buy from Hold at BB&T... WGL Holdings (WGL) upgraded to Buy from Hold at Brean Capital.
09:01 EDTJNJJohnson & Johnson remains undervalued, says Cowen
Subscribe for More Information
08:19 EDTTRNXTornier upgraded at BMO Capital
As noted earlier, BMO Capital upgraded Tornier to Outperform from Market Perform. After the company reported better than expected Q2 results, the firm thinks the results were very good and says that the business' visibility has increased. Target to $24 from $20.
06:22 EDTTRNXTornier upgraded to Outperform from Market Perform at BMO Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use